W e have recently shown that HAVCR1 is a functional hepatitis A virus (HAV) cellular receptor in clone GL37 of African green monkey kidney (GL37) cells that mediates cell entry of viral particles (vpHAV) and exosomes produced in HAV-infected cells (exo-HAV or eHAV) (1). We also showed that HAVCR1 is the predominant HAV receptor in GL37 cells, whereas alternative, yet-unidentified HAV receptors are coexpressed with HAVCR1 in other primate cells, such as Vero E6 and Huh7 cells (1). The knockout (KO) of HAVCR1 using CRISPR/Cas9 technology significantly reduced the susceptibility of GL37 cells to HAV infection, which was regained upon transfection of HAVCR1 cDNA (1), supporting the notion that resistance to HAV infection in these GL37 HAVCR1 KO cells is due to the lack of HAV receptors rather than other factors. Taken together with our previous work showing the direct interaction of HAV with HAVCR1 in cellular and cell-free systems (2-10), our data clearly indicated that HAVCR1 is indeed a functional HAV receptor of vpHAV and exo-HAV. For the letter to the editor of Das et al. (11), the Lemon lab and Maury lab (Lemon/Maury labs) tried to reproduce our results using GL37 cells and one of the sgRNAs that we described in our paper (1) but used a flawed experimental design that led them to conclude incorrectly that HAVCR1 was not a functional vpHAV receptor. The Lemon/Maury lab data clearly show that the susceptibility of vpHAV is reduced significantly in their GL37 HAVCR1 KO cells compared to that in wild-type GL37 (GL37 wt) cells (see Fig. 1D and E in reference 11). However, the HAV background level in their GL37 HAVCR1 KO cells was ϳ200 times higher than in ours (1), which is likely due to a combination of factors, including the CRISPR/Cas9 strategy used to generate their HAVCR1 KO cells (Fig. 1A), the short vpHAV adsorption times, and the high multiplicities of infection used in their experiments. The Lemon/ Maury labs produced their GL37 HAVCR1 KO cells using a single sgRNA cloned into a lentivirus vector to mediate a single cut in exon 2 of the HAVCR1 gene, selected the pool of puromycin-resistant transduced cells, verified that heterogeneous small insertions and deletions (indels) were introduced in exon 2, and used the uncloned heterogeneous cell population to analyze the function of HAVCR1 as an HAV receptor. This simple and fast procedure resulted in the selection of a pool of heterogeneous puromycin-resistant cells consisting mainly of HAVCR1 KO cells but also most likely containing cells with various degrees of susceptibility to vpHAV infection due to (i) small in-frame indels that did not prevent the HAV receptor function of HAVCR1, (ii) off-target events that conferred puromycin resistance but did not knock out HAVCR1, and (iii) expression of different levels of alternative HAV receptors that are not predominant in AGMK GL37 cells compared to in Vero and Huh7 cells (1), which would significantly increase the background level of HAV infection in their heterogenous pool of puromycin-resistant cells. To circum...